← Back to Search

Omega-3 fatty acid for Breast Cancer

N/A
Waitlist Available
Led By Zoneddy Dayao
Research Sponsored by New Mexico Cancer Care Alliance
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 month after completion of therapy
Awards & highlights

Study Summary

This trial will test whether omega-3 fatty acids can prevent or treat paclitaxel-associated acute pain syndrome (P-APS).

Eligible Conditions
  • Breast Cancer
  • Ovarian Neoplasms
  • Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 month after completion of therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month after completion of therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean severity of pain
Secondary outcome measures
Incidence of pain or relief

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Arm I (Omega-3 fatty acid)Experimental Treatment2 Interventions
Four Omega-3 fatty acid capsules (at 1 gram/capsule) are administered orally daily. The capsules may be administered either once daily or as 2 capsules two times daily.
Group II: Arm II (placebo)Placebo Group2 Interventions
Four placebo capsules (at 1 gram microcrystalline cellulose/capsule) are administered orally daily. The capsules may be administered either once daily or as 2 capsules two times daily.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Omega-3 fatty acid
2010
Completed Phase 4
~640
Paclitaxel
2011
Completed Phase 4
~5380

Find a Location

Who is running the clinical trial?

New Mexico Cancer Care AllianceLead Sponsor
70 Previous Clinical Trials
52,407 Total Patients Enrolled
4 Trials studying Breast Cancer
735 Patients Enrolled for Breast Cancer
Alliance Healthcare FoundationOTHER
Zoneddy DayaoPrincipal InvestigatorUniversity of New Mexico Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
2016. "Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01821833.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top